Thermo Fisher Scientific
Plainville, MA · Alachua, FL · Cambridge, MA
2 confirmed programs
· 2 sponsors
· Last scored 2026-04-02
83.2
Signal Score
✓ FDA Inspections (4)
✓ Clinical Trials (2)
✓ SEC Filings (14)
✓ Press (20)
✓ EMA GMP (1)
✓ MHRA GMP (9)
Quick Facts: Thermo Fisher Scientific
- Signal Score
- 83.2/100 (as of 2026-04-02)
- Quality Compliance
- 98.2/100
- Headquarters
- Plainville, MA · Alachua, FL · Cambridge, MA
- Modalities
- AAV, Lentiviral, Plasmid DNA, Adenoviral
- Active Programs
- 2 confirmed from ClinicalTrials.gov across 2 sponsors
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
- Scored By
- CDMO Signal — independent CDMO intelligence platform
Signal Score & Pillar Breakdown
Quality Compliance
98.2
FDA Inspections4 on record
Warning Letters0
Last InspectionNo Action Indicated (NAI) (2025-09-26)
EMA GMP Certificates1 on record
MHRA GMP Certificates9 on record
Operations
60.0
2 active programs across 2 sponsors
Modalities: AAV, Adenoviral, Plasmid DNA, Lentiviral
2 programs in advanced phases (Phase 2/3)
Source: ClinicalTrials.gov
2 active programs across 2 sponsors · Modalities: AAV, Adenoviral, Plasmid DNA, Lentiviral · 2 programs in advanced phases (Phase 2/3)
Programs
2
Sponsors2
ModalitiesAAV, Lentiviral, Plasmid DNA, Adenoviral
2 active programs across 2 sponsors
Modalities: AAV, Adenoviral, Plasmid DNA, Lentiviral
2 programs in advanced phases (Phase 2/3)
Source: ClinicalTrials.gov facility matching
Partnership Announcements (from press monitoring)
Source: ClinicalTrials.gov · Retrieved Apr 05, 2026
Financial Stability
78.0
Publicly traded — financial transparency
Moderate industry presence in SEC filings (10 mentions)
Source: SEC EDGAR, press monitoring
14 SEC filings with industry mentions on record
SEC Filings14 with industry mentions
Publicly traded — financial transparency
Moderate industry presence in SEC filings (10 mentions)
Capacity
91.0
3 manufacturing sites
Broad modality coverage (4 modalities)
2 facility investment mentions in SEC filings
Active facility expansion (3 articles)
Strong partnership activity (4 articles)
Sites: Plainville, MA, Lexington, MA, Alachua, FL
Source: SEC EDGAR, press monitoring, company profiles
3 manufacturing sites
StatusAvailable
3 manufacturing sites
Broad modality coverage (4 modalities)
2 facility investment mentions in SEC filings
Active facility expansion (3 articles)
Strong partnership activity (4 articles)
Regulatory milestones (2 articles)
Sites: Plainville, MA, Lexington, MA, Alachua, FL
Recent Press20 articles
3 manufacturing sites
Broad modality coverage (4 modalities)
2 facility investment mentions in SEC filings
Active facility expansion (3 articles)
Strong partnership activity (4 articles)
Regulatory milestones (2 articles)
FDA Inspection History
2025-09
2025-09
2025-07
2024-11
NAI
VAI
OAI
| Date | Site | Type | Observations | Classification |
|---|---|---|---|---|
| 2025-09-26 | Greenville, North Carolina | Drug Quality Assurance | No | No Action Indicated (NAI) |
| 2025-09-26 | Cincinnati, Ohio | Drug Quality Assurance | Yes | Voluntary Action Indicated (VAI) |
| 2025-07-17 | High Point, North Carolina | Drug Quality Assurance | Yes | Voluntary Action Indicated (VAI) |
| 2024-11-20 | Saint Louis, Missouri | Drug Quality Assurance | No | Voluntary Action Indicated (VAI) |
Source: FDA Data Dashboard · Retrieved Apr 05, 2026
EMA GMP Compliance 1 certificates
2025-11
Compliant
Non-Compliant
| Certificate | Site | Country | Inspection Date | Status |
|---|---|---|---|---|
| CRN00GTCX/ASR12633 | Thermo Fisher Scientific Cork Limited | Ireland | 2025-11-07 | COMPLIANT |
Source: EMA EudraGMDP · Retrieved Apr 05, 2026
MHRA GMP Compliance 9 certificates
2024-10
2024-10
2024-07
2024-07
2024-07
2021-03
2019-08
2019-01
2017-01
Compliant
Non-Compliant
| Certificate | Site | City / Postcode | Inspection Date | Status |
|---|---|---|---|---|
| UK MIA 18693 Insp GMP/GDP/IMP 18693/11204-0018[H] | FISHER CLINICAL SERVICES UK LIMITED | HORSHAM RH12 4QD | 2024-10-08 | COMPLIANT |
| UK MIA(IMP) 18693 Insp GMP/GDP/IMP 18693/11204-0019[I] | FISHER CLINICAL SERVICES UK LIMITED | HORSHAM RH12 4QD | 2024-10-08 | COMPLIANT |
| UK MIA 17857 Insp GMP/IMP 17857/10036-0034[H] | PATHEON UK LIMITED | SWINDON SN3 5BZ | 2024-07-29 | COMPLIANT |
| UK MIA(IMP) 17857 Insp GMP/IMP 17857/10036-0034[I] | PATHEON UK LIMITED | SWINDON SN3 5BZ | 2024-07-29 | COMPLIANT |
| UK MIA(IMP) 32390 Insp GMP/IMP 32390/411870-0007[I] | THERMO ELECTRON LIMITED | BISHOP'S STORTFORD CM23 5RG | 2024-07-16 | COMPLIANT |
| UK MIA(IMP) 17857 Insp GMP/IMP 17857/14285-0011[I] | PATHEON UK LIMITED | ABINGDON OX14 4SD | 2021-03-24 | COMPLIANT |
| UK MIA(IMP) 32390 Insp IMP 32390/18853104-0001[I] | THERMO ELECTRON LIMITED | STEVENAGE SG1 2FX | 2019-08-29 | COMPLIANT |
| UK MIA(IMP) 18693 Insp GMP/GDP/IMP 18693/11485563-0003[I] | FISHER CLINICAL SERVICES LIMITED | CRAWLEY RH10 9NL | 2019-01-21 | COMPLIANT |
| UK GMP 20788 Insp GMP 20788/13917-0005[H] | PATHEON PHARMACEUTICALS INCORPORATED | 45237 | 2017-01-17 | COMPLIANT |
Source: MHRA GMDP Database · Retrieved Apr 05, 2026
Clinical Activity 2 studies
NCT02340936
Clinical Trial to Determinate Dose, Security and Efficacy or Lenalidomide...
PHASE1/PHASE2
Completed
NCT00982111
First-line Treatment of Patients With Stage IV Nonsquamous Non-Small Cell...
PHASE3
Completed
Source: ClinicalTrials.gov · Retrieved Apr 05, 2026
Financial Intelligence
"Amounts expected to occur thereafter generally relate to contract manufacturing, clinical research and extended warranty service agreements, which typically have durations of
three
to
five years
."
"Amounts expected to occur thereafter generally relate to contract manufacturing, clinical research and extended warranty service agreements, which typically have durations of
three
to
five years
."
"Amounts expected to occur thereafter generally relate to contract manufacturing, clinical research and extended warranty service agreements, which typically have durations of
three
to
five years
."
"Amounts expected to occur thereafter generally relate to contract manufacturing, clinical research and extended warranty service agreements, which typically have durations of
three
to
five years
."
"Amounts expected to occur thereafter generally relate to contract manufacturing, clinical research and extended warranty service agreements, which typically have durations of
three
to
five years
."
"Amounts expected to occur thereafter generally relate to contract manufacturing, clinical research and extended warranty service agreements, which typically have durations of
three
to
five years
."
"Amounts expected to occur thereafter generally relate to contract manufacturing, clinical research and extended warranty service agreements, which typically have durations of
three
to
five years
."
"Amounts expected to occur thereafter generally relate to contract manufacturing, clinical research and extended warranty service agreements, which typically have durations of
three
to
five years
."
Source: SEC EDGAR · Retrieved Apr 05, 2026
Recent News 20 articles
Thermo Fisher Scientific Launches Integrated Platform to Accelerate Biologics Development - BioSpace
Thermo Fisher Scientific Launches Integrated Platform to Accelerate Biologics Development BioSpace
Thermo Fisher Scientific Introduces the Gibco™ CTS™ Compleo™ Fill and Finish System to Help Streamline Cell Therapy Manufacturing - Morningstar
Thermo Fisher Scientific Introduces the Gibco™ CTS™ Compleo™ Fill and Finish System to Help Streamline Cell Therapy Manufacturing Morningstar
Thermo Fisher Scientific Launches Gibco CHOvantage GS Cell Line Development Kit To Accelerate Biologics Development - biopharmaapac.com
Thermo Fisher Scientific Launches Gibco CHOvantage GS Cell Line Development Kit To Accelerate Biologics Development biopharmaapac.com
Aragen Life Sciences signs MoU with Thermo Fisher to advance biologics manufacturing - BioSpectrum India
Aragen Life Sciences signs MoU with Thermo Fisher to advance biologics manufacturing BioSpectrum India
Thermo Fisher and SHL Medical collaborate to integrate autoinjector assembly with sterile fill-finish at Ridgefield site - Manufacturing Chemist
Thermo Fisher and SHL Medical collaborate to integrate autoinjector assembly with sterile fill-finish at Ridgefield site Manufacturing Chemist
Thermo Fisher Scientific and SHL Medical Collaborate to Deliver Fully Integrated Drug-Device Solutions - Business Wire
Thermo Fisher Scientific and SHL Medical Collaborate to Deliver Fully Integrated Drug-Device Solutions Business Wire
Thermo Fisher Scientific and SHL Medical Collaborate to Deliver Fully Integrated Drug-Device Solutio - PharmiWeb.com
Thermo Fisher Scientific and SHL Medical Collaborate to Deliver Fully Integrated Drug-Device Solutio PharmiWeb.com
Thermo Fisher And SHL Medical Advance Integrated Drug Device Manufacturing With Ridgefield Expansion - BioPharma APAC
Thermo Fisher And SHL Medical Advance Integrated Drug Device Manufacturing With Ridgefield Expansion biopharmaapac.com
Thermo Fisher Scientific and SHL Medical Collaborate to Deliver Fully Integrated Drug-Device Solutions - BioSpace
Thermo Fisher Scientific and SHL Medical Collaborate to Deliver Fully Integrated Drug-Device Solutions BioSpace
Thermo Fisher Scientific supports Swindon with place-marketing campaign - Rayo
Thermo Fisher Scientific supports Swindon with place-marketing campaign Rayo
Thermo Fisher’s Moat Faces Margin Test as Cell & Gene Therapy Growth Accelerates - Bitget
Thermo Fisher’s Moat Faces Margin Test as Cell & Gene Therapy Growth Accelerates Bitget
Thermo Fisher’s Moat Faces Margin Test as Cell & Gene Therapy Growth Accelerates - Bitget
Thermo Fisher’s Moat Faces Margin Test as Cell & Gene Therapy Growth Accelerates Bitget
Thermo Fisher (TMO) Invests $2 Billion in U.S. Manufacturing - GuruFocus
Thermo Fisher (TMO) Invests $2 Billion in U.S. Manufacturing GuruFocus
Thermo Fisher (TMO) Invests $2 Billion in U.S. Manufacturing - GuruFocus
Thermo Fisher (TMO) Invests $2 Billion in U.S. Manufacturing gurufocus.com
Thermo Fisher Scientific opens new distribution centre in Meath - Silicon Republic
Thermo Fisher Scientific opens new distribution centre in Meath Silicon Republic
Thermo Fisher Scientific opens new distribution centre in Ireland - Med-Tech Insights
Thermo Fisher Scientific opens new distribution centre in Ireland Med-Tech Insights
Thermo Fisher adds DXR3 SmartRaman+ for non-destructive, at-line Raman QC - R&D World
Thermo Fisher adds DXR3 SmartRaman+ for non-destructive, at-line Raman QC R&D World
Lithuania’s manufacturing shift: Teltonika, Thermo Fisher & Orlen lead high-tech growth - LRT
Lithuania’s manufacturing shift: Teltonika, Thermo Fisher & Orlen lead high-tech growth LRT
$19.8 Billion Cell and Gene Therapy Tools & Reagents Market Outlook, 2030 Featuring Thermo Fisher Scientific, Cytiva (Danaher), Merck, Miltenyi Biotec, Sartorius and More - Yahoo Finance
$19.8 Billion Cell and Gene Therapy Tools & Reagents Market Outlook, 2030 Featuring Thermo Fisher Scientific, Cytiva (Danaher), Merck, Miltenyi Biotec, Sartorius and More Yahoo Finance
$19.8 Billion Cell and Gene Therapy Tools & Reagents Market Outlook, 2030 Featuring Thermo Fisher Scientific, Cytiva (Danaher), Merck, Miltenyi Biotec, Sartorius and More - Yahoo Finance UK
$19.8 Billion Cell and Gene Therapy Tools & Reagents Market Outlook, 2030 Featuring Thermo Fisher Scientific, Cytiva (Danaher), Merck, Miltenyi Biotec, Sartorius and More Yahoo Finance UK
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
Similar CDMOs
Catalent
Somerset, NJ (Now Novo Holdings)
Signal Score: 81.0
AAV, CAR-T, Lentiviral, Plasmid DNA
Exothera
Jumet, BE
Signal Score: 78.1
AAV, Adenoviral, Lentiviral
Advent Bioservices
London, UK
Signal Score: 78.1
AAV, Lentiviral, Adenoviral
Vigene Biosciences
Rockville, MD
Signal Score: 72.5
AAV, Lentiviral, Adenoviral
Charles River Laboratories
Newbury Park, CA · Memphis, TN · Keele, UK · Rockville, MD
Signal Score: 92.2
CAR-T, Cell Therapy, Gene Editing, Plasmid, AAV, Lentiviral